Smoking Prevention Program in Poland

August 4, 2022 updated by: Łukasz Moskal, MD, Wroclaw Medical University

Youth Smoking Prevention Program in Poland

Smoking Prevention Program is a pilot exploratory study with a standardized curriculum based on the Tobacco Prevention Toolkit from Stanford University and translated into Polish by the members of Students Scientific Association of Oncology at Wroclaw Medical University. The program will assess the effectiveness of a school-based smoking prevention curricula keeping children as never smokers and test the feasibility of engaging medical students and teachers in implementing and evaluating a validated program on smoking prevention within the Polish School System. The research protocols, methods and data collection instruments of a standardized classroom based valid tobacco prevention program from Stanford University will be used for the study. The smoking prevention program is centred on drug resistance, personal self-management and increasing social skills. The program increases knowledge and uses coaching and practice to provide students with the skills to resist social pressures around cigarette use. The secondary outcome of this study is to determine the change in attitudes by Polish Medical Student regarding Cancer Prevention Research. During Smoking Prevention Program workshops, the 5-Session Curriculum for primary schools will be translated, applied and evaluated for polish students.

This community-based pilot will engage medical students, the local school district and the local health authority. The Educational program meets the requirements set by Centers for Disease Control and Prevention (CDC) in Guidelines for School Health Programs to Prevent Tobacco Use and Addiction. Following parental consent, the program will be implemented with all 7th and 8th grade students (children age 12-15 years) from the Elementary School in Tyniec Mały. This project is supported by the Head of Lower Silesian Oncology Center, the Head of Department of Oncology of Wroclaw Medical University, the Health and Social Affairs Department of City of Wroclaw and under the patronage of the Lower Silesia Governor's Office, the Polish Society of Oncology, the Polish Society of Public Health, the Lower Silesian Department of Polish Society of Cardiology and the European Association for Cancer Education (EACE).

Smoking Prevention Program is funded by the READS Grant Program from the American Association for Cancer Education (AACE).

Study Overview

Study Type

Observational

Enrollment (Anticipated)

180

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lower Silesia
      • Wroclaw, Lower Silesia, Poland, 50-367
        • Wroclaw Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 15 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The program will be implemented with all 7th and 8th grade students (children age 12-15 years) from the Elementary School in Tyniec Mały.

Description

Inclusion Criteria:

  • Students from Tyniec Mały
  • 7th and 8th graders of the elementary school
  • Parental consent
  • Students consent

Exclusion Criteria:

  • Lack of parental consent
  • Lack of students consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
7th and 8th grade students (children age 12-15 years) from the elementary school
The program consists of five 50-minutes sessions conducted in person as scheduled during weekly class meetings. Educators will conduct workshops with PowerPoint presentations and worksheets dedicated to in-class activities.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Smoking intention
Time Frame: 2 months
Change in smoking intention among elementary school students after program completion (score based on survey results).
2 months
Knowledge of negative consequences of smoking
Time Frame: 2 months
Change in knowledge about adverse effects of smoking after program completion (score based on survey results).
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Łukasz Moskal, MD, Wroclaw Medical University
  • Principal Investigator: Konrad Reszka, MD, Wroclaw Medical University
  • Principal Investigator: Urszula Staszek-Szewczyk, MD, PhD, Wroclaw Regional Comprehensive Cancer Center, Department of Brachytherapy
  • Principal Investigator: Jagoda Łaba, MD, Wroclaw Medical University
  • Principal Investigator: Krzysztof Szewczyk, MD, PhD, Wroclaw Medical University, Department of Oncology, Division of Surgical Oncology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 15, 2022

Primary Completion (ANTICIPATED)

August 13, 2022

Study Completion (ANTICIPATED)

October 14, 2022

Study Registration Dates

First Submitted

July 29, 2022

First Submitted That Met QC Criteria

August 3, 2022

First Posted (ACTUAL)

August 5, 2022

Study Record Updates

Last Update Posted (ACTUAL)

August 9, 2022

Last Update Submitted That Met QC Criteria

August 4, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking

Clinical Trials on educational intervention

3
Subscribe